Correlation Between Premium Income and Cardiol Therapeutics

Can any of the company-specific risk be diversified away by investing in both Premium Income and Cardiol Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Premium Income and Cardiol Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Premium Income and Cardiol Therapeutics Class, you can compare the effects of market volatilities on Premium Income and Cardiol Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Premium Income with a short position of Cardiol Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Premium Income and Cardiol Therapeutics.

Diversification Opportunities for Premium Income and Cardiol Therapeutics

0.66

Correlation Coefficient

Premium Income  Cardiol Therapeutics

Poor diversification

The 3 months correlation between Premium and Cardiol is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Premium Income and Cardiol Therapeutics Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiol Therapeutics and Premium Income is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Premium Income are associated (or correlated) with Cardiol Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiol Therapeutics has no effect on the direction of Premium Income i.e., Premium Income and Cardiol Therapeutics go up and down completely randomly.

Pair Corralation between Premium Income and Cardiol Therapeutics

Assuming the 90 days trading horizon Premium Income is expected to generate 0.3 times more return on investment than Cardiol Therapeutics. However, Premium Income is 3.31 times less risky than Cardiol Therapeutics. It trades about -0.11 of its potential returns per unit of risk. Cardiol Therapeutics Class is currently generating about -0.12 per unit of risk. If you would invest  604.00  in Premium Income on December 3, 2024 and sell it today you would lose (64.00) from holding Premium Income or give up 10.6% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Premium Income  vs.  Cardiol Therapeutics Class

Premium Income

Risk-Adjusted Performance

Very Weak

Over the last 90 days Premium Income has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Cardiol Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cardiol Therapeutics Class has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Premium Income and Cardiol Therapeutics

The main advantage of trading using opposite Premium Income and Cardiol Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Premium Income position performs unexpectedly, Cardiol Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will offset losses from the drop in Cardiol Therapeutics' long position.

The idea behind Premium Income and Cardiol Therapeutics Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.